Oxford Immunotec Global (Oxford Immunotec Global) Inventory Turnover : 0.35 (As of Sep. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Oxford Immunotec Global Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Oxford Immunotec Global's Cost of Goods Sold for the three months ended in Sep. 2020 was $4.58 Mil. Oxford Immunotec Global's Average Total Inventories for the quarter that ended in Sep. 2020 was $12.96 Mil. Oxford Immunotec Global's Inventory Turnover for the quarter that ended in Sep. 2020 was 0.35.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Oxford Immunotec Global's Days Inventory for the three months ended in Sep. 2020 was 258.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Oxford Immunotec Global's Inventory-to-Revenue for the quarter that ended in Sep. 2020 was 0.67.

Oxford Immunotec Global Inventory Turnover Historical Data

The historical data trend for Oxford Immunotec Global's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Immunotec Global Inventory Turnover Chart

Oxford Immunotec Global Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Inventory Turnover

Get a 7-Day Free Trial

4.37

2.27

2.53

2.26

2.05

Oxford Immunotec Global Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Inventory Turnover	Get a 7-Day Free Trial															0.58	0.38	0.33	0.18	0.35

Oxford Immunotec Global Inventory Turnover Calculation

Oxford Immunotec Global's Inventory Turnover for the fiscal year that ended in Dec. 2019 is calculated as

	Inventory Turnover (A: Dec. 2019 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2019 )	/ (	(Total Inventories (A: Dec. 2018 )	+	Total Inventories (A: Dec. 2019 ))	/	count )
=	19.288	/ (	(7.767	+	11.096)	/	2 )
=	19.288	/	9.4315
=	2.05

Oxford Immunotec Global's Inventory Turnover for the quarter that ended in Sep. 2020 is calculated as

	Inventory Turnover (Q: Sep. 2020 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Sep. 2020 )	/ (	(Total Inventories (Q: Jun. 2020 )	+	Total Inventories (Q: Sep. 2020 ))	/	count )
=	4.578	/ (	(12.824	+	13.099)	/	2 )
=	4.578	/	12.9615
=	0.35

Oxford Immunotec Global (NAS:OXFD) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Oxford Immunotec Global's Days Inventory for the three months ended in Sep. 2020 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2020 )	/	Cost of Goods Sold (Q: Sep. 2020 )	*	Days in Period
	=	12.9615	/	4.578	*	365 / 4
	=	258.35

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Oxford Immunotec Global's Inventory to Revenue for the quarter that ended in Sep. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2020 )	/	Revenue (Q: Sep. 2020 )
	=	12.9615	/	19.436
	=	0.67

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Oxford Immunotec Global Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Oxford Immunotec Global's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Immunotec Global (Oxford Immunotec Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford Immunotec Global PLC (NAS:OXFD) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

143 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4SE

Website

http://www.oxfordimmunotec.com

Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.

Executives

Andrew Scott Walton	director	430 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark R. Klausner	director	C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Patricia Randall	director	C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Richard A Sandberg	director	330 NEVEDA STREET, NEWTON MA 02460-1458
Patrick J Balthrop	director	C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE MD 20850
Herm Rosenman	director	OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, HILTON PARK, SAN DIEGO X0 OX14 4RZ
James R Tobin	director	C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Ronald Asbury Andrews	director	5791 VAN ALLEN WAY, CARLSBAD CA 92008
Peter Wrighton-smith	director, officer: Chief Executive Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Mclaughlin Matthew T E	officer: Chief Financial Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Stefan C Linn	officer: Chief Operating Officer	C/O OXFORD IMMUNOTEC GLOBAL 940 INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Janet Louise Kidd	officer: General Counsel	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Elizabeth M Keiley	officer: SVP & General Counsel	C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Richard M. Altieri	officer: Chief Financial Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Richard Wenstrup	officer: Chief Medical Officer	C/O OXFORD IMMUNOTEC GLOBAL, 94C INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RZ